Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000291762 | SCV000350422 | uncertain significance | Congenital isolated adrenocorticotropic hormone deficiency | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV000430457 | SCV000522504 | likely benign | not specified | 2016-01-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Clinical Molecular Genetics Laboratory, |
RCV000291762 | SCV000805088 | benign | Congenital isolated adrenocorticotropic hormone deficiency | 2018-06-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000994162 | SCV001147503 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TBX19: PM2, PM3:Supporting, BP4 |
Labcorp Genetics |
RCV000994162 | SCV003273476 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 1 of the TBX19 gene. It does not directly change the encoded amino acid sequence of the TBX19 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs200043223, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TBX19-related conditions. ClinVar contains an entry for this variant (Variation ID: 293456). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003910063 | SCV004723972 | likely benign | TBX19-related disorder | 2019-08-01 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |